Delivery systems for molecular vaccination

Nadeem A. Sheikh, Mariam Al-Shamisi, W. John W. Morrow

Research output: Contribution to journalReview articlepeer-review

36 Citations (Scopus)


Vaccination is one of the medical success stories of the 20th century, however, there are many diseases for which no prophylactic regimes are available. A major hindrance that has prevented the development of effective mass immunization programs is the inability to induce an appropriate, protective, immune response. For example, for vaccines against intracellular pathogens there is a requirement for cell-mediated immunity as characterized by cytolytic T-lymphocyte activity. However, such a response can be extremely difficult to elicit, especially those employing recombinant, soluble protein subunits. This deficiency is due to the inability of these antigens to access the machinery of the appropriate antigen-processing pathway. Following an improved understanding of the mechanisms underlying such processing, as well as the realization that delivery systems can affect, quantitatively and qualitatively, the resulting immune response, the last decade has witnessed an intense research effort in this field. In this article we will review the major developments in the area of antigen delivery as related to vaccination.

Original languageEnglish
Pages (from-to)37-54
Number of pages18
JournalCurrent Opinion in Molecular Therapeutics
Issue number1
Publication statusPublished - 2000
Externally publishedYes


  • Adjuvant
  • Antigen
  • Copolymer
  • Cytokine
  • Saponin

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery
  • Genetics(clinical)


Dive into the research topics of 'Delivery systems for molecular vaccination'. Together they form a unique fingerprint.

Cite this